Valuation Valneva SE Pref. Euronext Paris

Stocks

Real-time Euronext Paris			5-day change	1st Jan Change
- ^EUR	-.--%		-.--%	-

08-14	Pfizer and Valneva Se Announce European Medicines Agency Validation of Marketing Authorization Application for Lyme Disease Vaccine Candidate	CI
08-14	Pfizer Inc. and Valneva Se Enter Strategic Alliance for Co-Development of Lyme Disease Vaccine Candidate	CI

Data adjusted to current consolidation scope

Fiscal Period: December	2021	2022	2023	2024	2025	2026	2027	2028
Market Cap ¹	2,574	861.1	655.1	351.1	642.3	513.9	-	-
Change	-	-66.55%	-23.93%	-46.4%	82.94%	-19.99%	-	-
Enterprise Value (EV) ¹	2,286	670.5	737.8	399.1	739.9	647.7	576.4	565.6
Change	-	-70.66%	10.04%	-45.9%	85.38%	-12.47%	-11%	-1.87%
P/E	-32.7x	-5.02x	-6.47x	-27x	-5.47x	-6.22x	9.81x	13x
PBR	15.1x	-	5.1x	1.94x	6.07x	9.58x	4.03x	2.97x
PEG	-	-0.1x	0.2x	0.3x	-0x	0.2x	-0x	-0.5x
Capitalization / Revenue	7.4x	2.38x	4.26x	2.07x	3.68x	3.4x	1.81x	2.07x
EV / Revenue	6.57x	1.86x	4.8x	2.35x	4.24x	4.29x	2.03x	2.28x
EV / EBITDA	-48.5x	-9.69x	-11.3x	12.1x	-12.5x	-19.3x	5.56x	10.5x
EV / EBIT	-37.2x	-5.91x	-8.99x	29.9x	-9.12x	-11.2x	7.46x	10.6x
EV / FCF	-140x	-2.44x	-3.4x	-4.92x	-12.9x	-13.8x	6.28x	74.1x
FCF Yield	-0.71%	-41%	-29.4%	-20.3%	-7.75%	-7.25%	15.9%	1.35%
Dividend per Share ²	-	-	-	-	-	-	-	-
Rate of return	-	-	-	-	-	-	-	-
EPS ²	-0.75	-1.24	-0.73	-0.08	-0.68	-0.4357	0.2762	0.2083
Distribution rate	-	-	-	-	-	-	-	-
Net sales ¹	348.1	361.3	153.7	169.6	174.7	151	283.4	248.4
EBITDA ¹	-47.1	-69.2	-65.24	32.92	-59.42	-33.62	103.7	53.7
EBIT ¹	-61.4	-113.4	-82.09	13.33	-81.16	-57.79	77.25	53.6
Net income ¹	-73.4	-143.3	-101.4	-12.25	-115.2	-81.11	53.07	28.74
Net Debt ¹	-288.9	-190.6	82.74	48.04	97.6	133.7	62.48	51.7
Reference price ²	24.500	6.224	4.720	2.162	3.718	2.710	2.710	2.710
Nbr of stocks (in thousands)	105,078	138,355	138,788	162,397	172,759	189,647	-	-
Announcement Date	2/3/22	3/23/23	3/21/24	3/20/25	3/17/26	-	-	-

¹EUR in Million²EUR

Estimates

Add to a list 0 selected To use this feature you must be a member Log in Sign up	P/E (Y)	EV / Sales (Y)	EV / EBITDA (Y)	Dividend Yield (Y)	Capi.($)
WUXI APPTEC CO., LTD.	20.87x	7.45x	14.96x	1.42%	71.53B
ARGENX SE	31.24x	9x	28.05x	0.04%	60.12B
LONZA GROUP AG	34.13x	6.11x	18.31x	0.95%	48.85B
IQVIA HOLDINGS INC.	34.64x	3.34x	14.41x	-.--%	44.28B
REVOLUTION MEDICINES, INC.	-21.08x	228.26x	-22.72x	-.--%	43.83B
BEONE MEDICINES AG	47.85x	5.53x	30.37x	-.--%	41.53B
CELLTRION, INC.	27.07x	7.8x	20.09x	0.42%	30.13B
WUXI BIOLOGICS (CAYMAN) INC.	32.39x	6.91x	17.94x	-.--%	27.98B
INSMED INCORPORATED	-70.94x	13.62x	-69.42x	-.--%	25.25B
Average	15.13x	32.00x	5.78x	0.32%	43.72B
Weighted average by Cap.	19.23x	31.83x	9.93x	0.42%